The DOI matches its Crossref record; 167 of the 171 references it cites were found in a registry or an index.
The PI3K/AKT pathway in obesity and type 2 diabetes
Open accessAbstract
Obesity and type 2 diabetes mellitus are complicated metabolic diseases that affect multiple organs and are characterized by hyperglycaemia. Currently, stable and effective treatments for obesity and type 2 diabetes mellitus are not available. Therefore, the mechanisms leading to obesity and diabetes and more effective ways to treat obesity and diabetes should be identified. Based on accumulated evidences, the PI3K/AKT signalling pathway is required for normal metabolism due to its characteristics, and its imbalance leads to the development of obesity and type 2 diabetes mellitus. This review focuses on the role of PI3K/AKT signalling in the skeletal muscle, adipose tissue, liver, brain and pancreas, and discusses how this signalling pathway affects the development of the aforementioned diseases. We also summarize evidences for recently identified therapeutic targets of the PI3K/AKT pathway as treatments for obesity and type 2 diabetes mellitus. PI3K/AKT pathway damaged in various tissues of the body leads to obesity and type 2 diabetes as the result of insulin resistance, and in turn, insulin resistance exacerbates the PI3K/AKT pathway, forming a vicious circle.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“AKT activation leads to increased glucose transporter 4 (GLUT4) expression and translocation, ultimately leading to increased glucose uptake.”
From Non-Diabetic Hypoglycemia: Evaluation and Management in Adults (2025) · cites this paper as [48]
The cited source says what the claim attributes to it.
In the citing paper
“PI3K is an enzyme that activates protein kinase B (AKT), which regulates glucose metabolism, among other intracellular functions [48].”
From Non-Diabetic Hypoglycemia: Evaluation and Management in Adults (2025) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509 · cited 1×
“AKT-mediated mTORC1 activation regulates a number of downstream effectors proteins through phosphorylation, including the well-characterized effectors p70 ribosomal S6 protein kinase-1 (S6K1) and eukaryotic translation initiation factor-4E (eIF4E)binding protein-1 (4E-BP1), to increase protein synthesis [43, 44].”
BackgroundPhosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216 · cited 1×
“First, phosphorylation of the threonine 308 (AKT1) in the kinase domain by phosphoinositide-dependent protein kinase 1 (PDK1) initiates the activation process [19], subsequent phosphorylation at serine 473 (AKT1) in the carboxy-terminal regulatory domain through mTOR complex 2 (mTORC2)[17, 20], which is activated by a…”
BackgroundAKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115 · cited 1×
“AKT regulates two processes by glycolysis Glucose 6-phosphate and glycogen synthase kinase 3 (GSK3) to produce cellular energy via glycolysis and promotes glycogen production by inhibiting [30].”
BackgroundMechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448 · cited 1×
“In obese subjects, excess levels of circulating FFAs, which are caused by a blunted response of adipose tissues, impairs the function of β cells [150].”
BackgroundInhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244 · cited 8×
“In the feeding state, SREBP-1c is regulated by four pathways: activated AKT stimulates liver X receptor (LXR), which is require for SREBP-1c transcription [64]; activated AKT stimulates mTORC1 to activate SREBP-1c transcription, and mTORC1 also inhibits Lipin-1, which decreases the half-life of nuclear SREBP-1c [65, 6…”
BackgroundInfluentialAKT/PKB Signaling: Navigating the Network
Manning, B. D., & Toker, A. (2017) · Cell · doi:10.1016/j.cell.2017.04.001 · Cited by 3,772 · cited 2×
“Similar phosphorylation events are observed at corresponding residues in AKT2 (T309 and S474) and AKT3 (T305 and S472) [22].”
BackgroundRole of leptin in the neuroendocrine response to fasting
Ahima, R. S., Prabakaran, D., Mantzoros, C., Qu, D., Lowell, B., Maratos-Flier, E., & Flier, J. S. (1996) · Nature · doi:10.1038/382250a0 · Cited by 3,117 · cited 1×
“In the presence of persistent excess energy availability, leptin signalling activates other pathways, such as STAT3 or SH2-containing tyrosine phosphatase, to predominantly regulate food intake in POMC neurons [90, 113, 119].”
BackgroundAlessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 2,874 · cited 1×
“First, phosphorylation of the threonine 308 (AKT1) in the kinase domain by phosphoinositide-dependent protein kinase 1 (PDK1) initiates the activation process [19], subsequent phosphorylation at serine 473 (AKT1) in the carboxy-terminal regulatory domain through mTOR complex 2 (mTORC2)[17, 20], which is activated by a…”
BackgroundEndoplasmic reticulum stress and the inflammatory basis of metabolic disease
Hotamisligil, G. S. (2010) · Cell · doi:10.1016/j.cell.2010.02.034 · Cited by 2,802 · cited 1×
“Chronic metabolic inflammation and endoplasmic reticulum (ER) stress also impair hepatic insulin-AKT signalling and subsequently causes insulin resistance [106, 107].”
BackgroundHealth and economic burden of the projected obesity trends in the USA and the UK
Wang, Y. C., McPherson, K., Marsh, T., Gortmaker, S. L., & Brown, M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60814-3 · Cited by 2,775 · cited 1×
“The prevalence of obesity has grown at an alarming rate although specific public health policies and treatment efforts have been developed to resist the obesity epidemic [1], potentially leading to increased numbers of patients affected by complications of obesity, such as the most devastating type 2 diabetes mellitus…”
Background
Flagged first, then by citations
4 of the 171 references couldn’t be matched to a known paper.
Research works printed but not linked: 5
- [98]Yecies Jessica L Zhang Hui H Menon S Liu S Yecies D Lipovsky Alex I Akt Stimulates Hepatic SREBP1c and Lipogenesis through Parallel mTORC1-Dependent and Independent Pathways Cell metabolism 2011 14 1 21 32 21723501 PMC3652544
- [120]Al-Qassab H Smith MA Irvine EE Guillermet-Guibert J Claret M Choudhury AI Dominant role of the p110beta isoform of PI3K over p110alpha in energy homeostasis regulation by POMC and AgRP neurons Cell metabolism 2009 10 5 343 54 19883613 PMC2806524
- [144]Bernal-Mizrachi E Wen W Stahlhut S Welling CM Permutt MA Islet beta cell expression of constitutively active Akt1/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia J Clin Invest 2001 108 11 1631 8 11733558 PMC200992
- [147]Wang HW Mizuta M Saitoh Y Noma K Ueno H Nakazato M Glucagon-like peptide-1 and candesartan additively improve glucolipotoxicity in pancreatic beta-cells Metabolism 2011 60 8 1081 9 21255808
- [161]Villani V Milanesi A Sedrakyan S Da Sacco S Angelow S Conconi MT Amniotic fluid stem cells prevent beta-cell injury Cytotherapy 2014 16 1 41 55 24210784 PMC4374982
Cited by
Sorted by citations
Items 901–1,000 of 1,008
Dong, H., Hao, L.-Y., Guo, W., Sun, X.-G., & Zhou, Z. (2026) · International Journal on Biological Sciences · doi:10.7150/ijbs.128084
“5C), supporting a critical role of BATF3 in maintaining hepatic insulin signaling [28, 29].”
The effect of insulin on 28-day mortality in non-diabetic sepsis patients: a retrospective study
Liu, Y.-F., Yue, J., Liu, N., Jiang, Y., Wang, G.-D., & Shu, A.-H. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1806847
Hussein, R. A., Salama, A., Halawa, E. M., Ali, G. H., & Afifi, A. H. (2026) · AMB Express · doi:10.1186/s13568-026-02043-3
“The PI3K/AKT signaling cascade is central to insulin action and glucose metabolism (Huang et al. 2018; Schul-tze et al. 2012; Tsay and Wang 2023).”
Xu, W., & Xu, S. (2026) · BMC Public Health · doi:10.1186/s12889-026-27253-z
“Insulin can activate downstream RAS/MAPK and PI3K/Akt signaling pathways through certain receptors [26, 27].”
Luo, J., Luo, J., Huang, Y., Lei, Q., Wu, Y., Han, B., & Xu, B. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c17741
Ahmad, I., de Mello, J. E., da Silveira, L. M., de Aguiar, M. S. S., Vizzotto, M., Domingues, W., de Souza, L. P., Campos, V. F., Tavares, R. G., Spanevello, R., et al. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11735-9
“It is reported that drugs enhancing this pathway can significantly improve insulin sensitivity and contribute to the management of T2DM [6 ].”
Jadhav, S. Y., & Noor, A. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.108570
Zhang, X., Zhou, Y., Zhou, H., Wang, P., Huang, Y., Lin, X., Xie, F.-Y., Zhang, Y., Zhou, J., Fu, C.-M., et al. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.121610
Hadi, S., Setiawan, D., Komari, N., Rahman, A., Nastiti, K., Noval, N., & Kuncoro, H. (2026) · Journal of HerbMed Pharmacology · doi:10.34172/jhp.2026.53362
“Other categories of differential expression included cellular signaling pathways, such as the PI3K-Akt and AMPK pathways, which contributed to energy metabolism and insulin response, respectively (33).”
Weng, X., Huang, M., & Wang, W. (2026) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2026.112809
Wang, Y.-B., Zang, X., Zhang, J., Liu, M., Liao, F., Han, B., Zhang, G.-F., Du, P., Li, C., & Liu, L.-B. (2026) · International Dairy Journal · doi:10.1016/j.idairyj.2026.106669
Yu, G., Ren, X., Guo, X., Guo, Y.-F., Qi, L., & Wang, L. (2026) · Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · doi:10.11817/j.issn.1672-7347.2026.250663
“Impairment of this pathway decreases fatty acid oxidation, exacerbates lipid accumulation, and further inhibits insulin signaling [54-55] .”
α-Glucosidase inhibitor: identifying key targets and mechanisms in type 2 diabetes.
Garg, S., Vijh, D., Gupta, P., Gupta, J., & Malik, M. Z. (2026) · 3 Biotech · doi:10.1007/s13205-026-04772-5
Commentary: E4orf1 as a key modulator in oncogenesis and of metabolism in Adenovirus infection
Nateqi, M., Hegde, V., & Dhurandhar, N. (2026) · Frontiers in Virology · doi:10.3389/fviro.2026.1726196
Yang, K., Li, J., Wang, L., Yu, H., Liu, X.-Y., Gao, Z., Wang, Z., Zhang, L.-Q., & Yang, H.-T. (2026) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-026-05333-2
Liu, Y., Zhu, M., Su, Q., Liu, M., Zhao, Z., & Ma, P. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18030349
Obstructive Sleep Apnea Syndrome and Ischemic Stroke: Investigating Inflammatory Mechanisms
Zhang, Z., Zhu, Z., Chen, Z., Liu, X., Yu, W., Aqdas, T., & Yuan, R. R. (2026) · Nature and Science of Sleep · doi:10.2147/nss.s581040
Alasmari, A., & Panneerselvam, C. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.178808
Li, X., Zhao, Y., Liao, A.-M., Pan, L., Xing, Y., Cheng, J.-J., Liu, J., & Huang, J.-H. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.108774
Obesogens in Prostate Cancer: An Endocrine and Metabolic Threat
Feijó, M., Fonseca, L. R. S., Kiss‐Toth, E., Socorro, S., & Correia, S. T. (2026) · Current Obesity Reports · doi:10.1007/s13679-026-00690-y
“Accordingly, the dysregulation of this signalling pathway contributes to the development of obesity and the chronic inflammation and metabolic dys - regulation in adipose tissue [56, 57].”
Sun, Y., Wang, X., Liu, H., Zhou, X., & Ma, Q. (2026) · Foods · doi:10.3390/foods15050806
Huang, J., Danzeng, Z., Gesang, L., Bai, C., Suona, Y., Zhang, R., Ciren, Z., Yuan, C., Baima, Y., Wang, Y.-S., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-38806-y
Predicting gestational diabetes mellitus early: insights from biochemical and molecular predictors
Zhang, T., Li, C., Zhang, Y., Ji, C., & Huang, H. (2026) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-026-01623-0
Puri, S., Singh, G., Singh, Y., Prakash, C., Kumar, A., Giri, S. K., & Ram, G. (2026) · Environment Conservation Journal · doi:10.36953/ecj.37123243
“Cinnamon attenuates insulin resistance by inhibiting proinflammatory cytokines and lipogenic genes (Huang et al., 2018).”
Ali, T., & Mishra, G. P. (2026) · Comparative Clinical Pathology · doi:10.1007/s00580-026-03763-5
“By restoring the PI3K/AKT pathway, CAR and THY decrease pancreatic β-cell death, lower blood glucose levels, and improve insulin sensitivity.”
InfluentialSystemic Loss of FKBPL Uncovers Diabetes-Dependent Pathways of Myocardial and Vascular Injury.
Alqudah, A., Edgar, K. S., O’Neill, K. M., McNally, R., Zhand, S., Le, N., Chhor, M., Short, A., Kavurma, M., López-Campos, G., et al. (2026) · Arteriosclerosis, Thrombosis and Vascular Biology · doi:10.1161/atvbaha.125.323053
Wu, P., Wang, Z., Li, K., Gao, Y., Yang, J., Wang, J., Shan, C., Guo, Q., Yang, H., Wang, J., et al. (2026) · PLoS ONE · doi:10.1371/journal.pone.0341129
“By modifying the signaling pathways involved in glucose uptake, exercise can help treat abnormalities in glucose metabolism [43].”
Zhong, X., Wei, Q., Tiwari, A., Wang, Q., Tan, Y., Chen, R., Yan, Y., Cox, N. J., & Bingshan, L. (2026) · npj Drug Discovery. · doi:10.1038/s44386-025-00032-3 · Cited by 3
“Among the list, we uncovered known T2D genes, e.g., INS 24 , IRS1 25 , PIK3R1 26,27 , and PIK3CA 28 that are important in T2D pathophysiology.”
Sonavane, O. A. P. A. K. B. (2026) · International Journal of Advanced Research in Science Communication and Technology · doi:10.48175/ijarsct-31143
Ramaswamy, P., Misra, P., Bajaj, S., Ankita, G., Ruchira, G., Arathi, P., Mukherjee, B., Gupta, A., Vashum, Y., Parmar, A., et al. (2026) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-026-01397-6
Lin, H.-Z., Liang, Z.-K., Huang, J.-J., Yang, Y., Huang, Y., Wu, Z.-S., Tan, J.-L., Huang, S. J., Ruan, S.-H., Xu, B.-Y., et al. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-026-02829-z
“The PI3K/ Akt pathway is recognized as a crucial pathway and plays essential roles in various physiological processes including glucose homeostasis, lipid metabolism, and protein syn - thesis [ 43 – 45 ].”
Meena, P., Vasuhi, M., Jeyalakshmi, S., & Gurupackiam, S. (2026) · International Journal For Multidisciplinary Research · doi:10.36948/ijfmr.0000.ic-aircm-t3-2026.1624
Iheagwam, F. N., Ayeni, T. O., & Oduselu, G. O. (2026) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2026.100232
Yang, R., Jiangfan, G., Wang, N., Qi, Z., Liu, C., Li, Q., Wu, L., Qin, L., & Liu, T. (2026) · Natural Product Communications · doi:10.1177/1934578x261420563
“40,41 Although downstream signaling molecules glycogen synthase and liver glycogen level were not quantitatively analyzed, PAS staining and oil red O staining of the liver suggested that hepatic glycogen synthesis was increased and lipid accumulation was reduced in the Fanqi Tea and exercise groups.”
Self-citationWang, Z., Liu, S., Gao, M., Shen, Y., Sun, M., & Hao, S. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116375
Du, X.-Y., Liu, M., Lei, L., Wang, Y., Gao, W., Du, X., Song, Y.-X., Liu, G., Li, X.-W., Ren, T., et al. (2026) · Veterinary Sciences · doi:10.3390/vetsci13020157
“The PI3K-Akt pathway is essential for regulating lipid and protein metabolism and is also associated with cell proliferation [41].”
Self-citationZanfardino, P., Amati, A., Iacobellis, D., Colella, M., & Petruzzella, V. (2026) · Scientific Reports · doi:10.1038/s41598-026-37423-z
Ma, H.-K., Meng, L., Shen, L., & Ji, H.-F. (2026) · Foods · doi:10.3390/foods15030453
“Among these, PIK3CA and PIK3R1, as members of the PI3K family, can activate AKT (e.g., AKT1), which in turn modulates various downstream substrates through serine and/or threonine phosphorylation, thereby influencing cellular metabolic functions [73].”
Wang, Z., Liu, S.-Y., Gao, M., Shen, Y., Sun, M., & Hao, S. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116251 · Cited by 2
Lee, D., Kim, J., Jeong, J.-H., Jo, J.-H., Park, Y.-T., Kim, Y.-J., Ham, J., Kim, T., & Kang, K.-S. (2026) · Processes · doi:10.3390/pr14020295
Zhou, J., Shi, W., Jiang, Y.-Y., & Yue, R.-S. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11446-1
“Overactivated GSK3β can phosphorylate tau protein, promoting its aggregation into neurofibrillary tangles [ 53, 54].”
Research on rhubarb's natural components and their potential for treating chronic kidney disease
Chen, M., Yao, J., & Liu, Z. (2026) · Tissue and Cell · doi:10.1016/j.tice.2026.103321
Marianne, M., Hasibuan, P. A., Yuandani, Y., Rullah, K., Uddin, M. N., Jeon, Y. A., & Lee, Y. J. (2026) · Journal of HerbMed Pharmacology · doi:10.34172/jhp.2026.53352
“Due to its strong mechanistic relevance and robust literature support, GSK3β was selected as the primary docking target to rationalize the observed insulin-mimetic activity of the extract and its compounds.”
InfluentialHou, Y., Wang, D., Liu, L., Tian, J., Zhi, M., & Shi, Y. (2026) · Experimental Cell Research · doi:10.1016/j.yexcr.2026.114897
Mekonnen, Z., Petito, G., Shitaye, G., D’Abrosca, G., Legesse, B. A., Addisu, S., Lanni, A., Fattorusso, R., Isernia, C., Comune, L., et al. (2026) · Molecules · doi:10.3390/molecules31020307
“Insulin sensitivity in skeletal muscle is primarily regulated through the IRS-1/PI3K/Akt pathway, which mediates glucose uptake and glycogen synthesis, whereas the AMPK–mTOR axis plays a pivotal role in cellular energy homeostasis and lipid metabolism [23,24].”
Targeting TRAF7: a new approach to modulate AKT in acute lung injury.
Billiar, T. R. (2026) · Science Bulletin · doi:10.1016/j.scib.2026.01.053
Acupotomy Activates PI3K/Akt Signaling Pathway Mediated by FGF7,10/KDR Axis to Regulate Apoptosis
Qian, J.-D., Wang, X., Fang, T., Liu, L., Liu, F., Zhao, X., & Tumurbaatar, K. (2026) · Journal of Pain Research · doi:10.2147/jpr.s557937
“39 Akt phosphorylates BAD to separate it from bcl-2/ bcl-XL, thereby inhibiting the mitochondrial release of cytochrome C and apoptosis-inducing factor (AIF).”
Diabetic signature on Parkinson’s disease: Insights into pathophysiology and therapeutic repurposing
Venugopal, R., Vijayaraghavan, A., Krishnan, S., Puthenveedu, D. K., Surendran, V., & Sachithanandan, S. (2026) · Annals of Movement Disorders · doi:10.4103/aomd.aomd_64_25
Wu, S.-X., Zuo, C., Bai, C., Chen, Q., Qiao, Y.-C., Zhou, N., & Xiao, Q. (2026) · Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy · doi:10.2147/dmso.s577700
“11,12 In parallel, insulin-like growth factor 1 (IGF1), which shares structural homology and receptor crosstalk with insulin, enhances insulin sensitivity and supports metabolic regulation.”
Zhang, J., Gao, W.-B., Hu, S.-H., & Liu, Y. (2025) · Advances in World Medical Research · doi:10.71204/83zf0y22
“…glucose metabolism primarily by activating the phosphatidylinositol-3-kinase (PI3K)/protein kinase B (Akt) and adenosine monophosphate-activated protein kinase (AMPK) pathways, both of which are pivotal in enhancing insulin sensitivity and energy balance (Herzig and Shaw, 2018; Huang et al., 2018).”
Ghosh, K., & Paul, G. (2025) · Cell and Tissue Biology · doi:10.1134/s1990519x25600565
“In contrast, AKT1 and AKT3 are more involved in promoting cell survival and regulating immune responses (Huang et al., 2018).”
Abdi, M., Moghaddam, V., & Fattahi, F. (2025) · Journal of Shahrekord University of Medical Sciences · doi:10.34172/jsums.1073
“This active Akt subsequently promotes glucose transporter type 4 translocation to the plasma membrane, markedly enhancing insulin-stimulated glucose uptake in obese subjects (21).”
Shi, K., Pei, Z., Quan, S., Shi, Y., & Zhou, Y. (2025) · Medicine · doi:10.1097/md.0000000000046737
“Simultaneously, insulin resistance disrupts the signaling pathway, [33,34] leading to reduced secretion of the anti-inflammatory cytokine.”
Wu, X., Qiu, Y., Dai, R., Huang, Z., Wang, J.-H., Yan, X., Nie, X.-Z., & Liu, R. (2025) · Scientific Reports · doi:10.1038/s41598-025-30778-9
“…node, enhancing insulin sensitivity through the PI3K-Akt signaling by promoting glucose transporter type 4 (GLUT4)-mediated glucose uptake and inhibiting hepatic gluconeogenesis via forkhead box protein O1 (FOXO1) 56–58 , while also counteracting inflammation by suppressing TNF/NF-κB signaling 59 .”
Cai, Y.-W., Tang, L., Zhu, Y., Ye, S.-S., & Chen, T.-E. (2025) · Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy · doi:10.2147/dmso.s549884
“21,22 Dysregulation of the PI3K/AKT pathway is a hallmark of IR.”
Lee, D., Liu, J., Lee, S. J., Lamichhane, G., Swayze, A., Zhang, G., Kim, T. Y., Egan, J. M., & Kim, Y. (2025) · Journal of Nutrition · doi:10.1016/j.tjnut.2025.101310
Lee, Y.-J., Xu, Y., & Hyun, C. (2025) · Pharmaceuticals · doi:10.3390/ph18121780 · Cited by 1
“However, by inhibiting AKT phosphorylation, it is possible to discourage adipocyte differentiation and regulate lipid metabolism, thereby preventing lipid accumulation [31].”
Transgenic overexpression of miR-486 and sAnk1.5 does not alter glucose handling in mice.
Buonocore, S., Fiore, F., Rubino, E. M., Catallo, M. R., Raucci, L., Laurino, A., Rossi, D., Pierantozzi, E., & Sorrentino, V. (2025) · Biochimica et biophysica acta. Molecular cell research · doi:10.1016/j.bbamcr.2025.120087
Hu, Y.-Y., Qian, R., He, Y.-F., Gao, Q.-Q., Wang, X., Lin, H.-L., Lin, W., Fang, Y., Zhu, J.-H., Wang, X.-Y., et al. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05372-9
“PI3K/AKT signaling plays a dominant role in neuronal survival, polarity, axon specificity, and synaptic plasticity, thereby influencing cerebral development and functions, which have been implicated in a variety of neurological impairments [45, 46].”
Network pharmacology and experiments verify the effect of triptolide on extraocular muscle fibrosis
Jiang, M., Wang, P., Yu, D.-D., Guo, P., Qu, Z., Zhao, J., & Yan, S. (2025) · PLoS ONE · doi:10.1371/journal.pone.0336487
“This recruits and activates AKT, which phosphorylates downstream targets by translocating to cellular compartments such as the nucleus, mitochondria, and endoplasmic reticulum [37].”
Bidirectional regulation of free fatty acid receptors and non-alcoholic fatty liver disease.
Lin, Y., Liu, Y., Liu, J., Wu, J., Wei, K.-H., Guo, J., & Su, Z.-Q. (2025) · Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2025.110180
Self-citationNetwork pharmacology based study of TCM formulations for non-insulin dependent diabetes mellitus
Jha, A., Venkatesh, S. K. S., & Lakkaniga, N. R. (2025) · In Silico Pharmacology · doi:10.1007/s40203-025-00451-0
“…glycogen synthesis, TSC2 to stimulate mTORC1-driven protein and lipid synthesis, FoxOs to suppress glu - coneogenesis, and AS160 to enhance glucose uptake, while also inhibiting lipolysis in adipose tissue and supporting β-cell survival and insulin secretion in the pancreas (Huang et al. 2018).”
Chander, R., Sharma, R., & Agnihotri, V. K. (2025) · Natural Product Research · doi:10.1080/14786419.2025.2572038
Gao, M.-Y., Zhang, X., Wang, Y., Li, Z.-S., Li, P., Feng, W.-R., Shu, Y.-X., & Li, W.-D. (2025) · Journal of Berry Research · doi:10.1177/18785093251382480
“17 Critically, Akt phosphorylation is essential for regulating FoxO1 activity.”
Chen, R., Wu, S., Zhang, Z., Li, K., Chen, J., Yang, N., Zhao, H., & Zhang, R. (2025) · Algal Research · doi:10.1016/j.algal.2025.104318
In silico of Secondary Metabolite Compounds in Garcinia mangostana as A Therapy for Type 2 Diabetes
Darmawansyih, D., Natzir, R., Yustisia, I., Hamid, F., Saleh, A., & Syakri, S. (2025) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2025.00670
Discovery of placental microRNAs associated with maternal insulin sensitivity during pregnancy
Majid, S., Soukar, I., White, F., Allard, C., Aguet, F., Ardlie, K., Florez, J. C., Edlow, A. G., Jacques, P., Karumanchi, S. A., et al. (2025) · Placenta · doi:10.1016/j.placenta.2025.10.021
Park, E., Kwak, S., Lim, A., Lee, S.-J., Park, M. S., Lee, Y.-J., Kim, S. E., Cho, Y., Lee, P., Lee, H.-S., et al. (2025) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2025.069
“This pathway is central to insulin signaling and plays a crucial role in suppressing he-patic lipogenesis and promoting lipid oxidation (Boucher et al ., 2010; Huang et al ., 2018; Wang et al ., 2023).”
Juwale, M. G., Kamble, A., Munot, H., & Kulkarni, A. (2025) · Chemistry and Biodiversity · doi:10.1002/cbdv.202500163
“PI3K protein plays a crucial role in both cancer and T2DM as the activation of this protein stimulates the responses of metabolism and proliferation along with tumour development and resistance to anticancer therapies [29].”
Xia, L., Yue, J.-Z., Wu, L.-J., Jin, Q., Yang, Y.-P., Yu, J., Pan, R.-Z., Zhang, X., Wu, X.-Y., Zhu, J.-Y., et al. (2025) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2025.117544
Choi, J.-S., Lee, G., An, J., Park, S., Choi, E. J., & Choi, S. (2025) · Medical Biological Science and Engineering · doi:10.30579/mbse.2025.8.2.82
Rasid, E. N. I., Ferdousi, F., Sasaki, K., Toda, K., Takahashi, S., Maeda‐Yamamoto, M., & Isoda, H. (2025) · Food Frontiers · doi:10.1002/fft2.70070
Exosomal MicroRNAs: A Diet-Induced Mediator of Glucose Metabolism
Li, Q., Xi, N., Wang, Z., Liu, H., Fang, H., & Liu, J. (2025) · Food Reviews International · doi:10.1080/87559129.2025.2526672
“[65] microRNAs could regulate insulin sensitivity and insulin stimulated glucose metabolism in muscle.”
Fu-Fang-Qi-Di-Hua-Yu-Tang Improves Diabetic Macrovascular Disease via PI3K/AKT Pathway Regulation
Zhang, S., Yan, M., Liang, P., Ye, Z., Liu, J., Huang, H. M., Li, G., & Wu, H. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s515521
Trabelsi, G., Mellado, S., Kalboussi, Z., Ghédira, L. C., & Pascual, M. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01654-0
“Based on the identified phytochemicals, we believe that the observed effects may be mediated, at least in part, by the activation of the PI3K/Akt pathway, known for its role in regulating carbohydrate metabolism and insulin secretion [48 , 49 ].”
Akkermansia muciniphila: A Promising Next Generation Probiotic
Hasnain, M. A., & Moon, G. (2025) · Current Topic in Lactic Acid Bacteria and Probiotics · doi:10.35732/ctlabp.2025.11.1.1 · Cited by 1
Crossman, D., Guo, G., Shanks, J., Pachen, M., Bai, J., Moammer, H., Middleditch, M., Grey, A., Paton, J., & Ramachandra, R. (2025) · bioRxiv · doi:10.1101/2025.05.29.656916
“Notably, PI3K-Akt signalling regulates metabolism, and its dysfunction leads to obesity and diabetes 39 .”
Caiazzo, S., Watt, M. J., Dodd, G. T., Bayliss, J. A., Thomas, H., Smith, L. K., Mitchell, C. B., & Phillips, W. A. (2025) · PLoS ONE · doi:10.1371/journal.pone.0322544
“While this data would seem to be in disagreement with the known role of PI3K to inhibit lipolysis through inhibition of protein kinase A (PKA) [10], Duncan and colleagues have previously shown that lipolysis is stimulated during fasting [19], providing a potential explanation for the increased…”
Unraveling Early Molecular Signatures of Type 2 Diabetes: A Multi-Omics Integration Using MOFA+
Omran, M. M., Alhfnawy, A. M., Gamaleldin, M., Abushady, A. M., Khalil, H., Demerdash, H., Elattar, M., & El-Hadidi, M. S. (2025) · International Conference on Machine Intelligence and Smart Innovation (ICMISI) · doi:10.1109/icmisi65108.2025.11115188
Beyond Base Camp: Promise and Pitfalls of PI3K/mTOR Inhibition in Pediatric High- Grade GliomasPreprint
Duchatel, R. J., Savary, C., Germon, Z. P., Riley, M., Ziegler, D. S., Mueller, S., Jackson, E. R., & Dun, M. D. (2025) · Research Square · doi:10.21203/rs.3.rs-6508597/v1 · Cited by 1
“PI3K/Akt signaling, particularly downregulating AKT2, facilitates insulin-driven glucose uptake in muscle, liver, and fat cells by promoting the glucose transporters translation to the plasma membrane [45].”
Zhao, X., Zhang, Y., & Ge, P. (2025) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2025.102502
Zhang, Y., Wang, B., Chen, B., & Wan, Q. (2025) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188251343140
“46 This study has several significant strengths.”
Wang, Y., Zhang, T., Li, Z., Mu, Z., Li, W., Zhang, H., & Wang, Z. (2025) · Journal of Berry Research · doi:10.1177/18785093251333065
The Physiological Role of GABA in Fine-Tuning Control of Blood Glucose and Diabetes Treatment
Davari, M., Sohrabipour, S., & Golkari, A. (2024) · Disease and Diagnosis · doi:10.34172/ddj.1595
“GABA improves glucose tolerance and insulin resistance by increasing GLUT4.”
InfluentialNeurological Impact of Diabetes, and Stem Cell as a Course of Action
Noor, R., Varkey, J., Torremocha, V., & Kethar, J. (2024) · Journal of Student Research · doi:10.47611/jsrhs.v13i4.8432
“When Akt receives insulin, it begins the process of metabolizing substances such as proteins and glucose (Huang et al., 2018).”
Li, N., Li, X., Guo, Y., Gu, J., Zhang, B., Zheng, F. Y., Pi, Z., & Yue, H. (2024) · International Conference on Public Health and Data Science (ICPHDS) · doi:10.1145/3718677.3718702
“The PI3K/AKT signaling pathway, integral to cell growth, proliferation, metabolism, survival, and cell cycle regulation [ 28 – 30 ] , and is closely related to cellular oxidative stress [ 31 , 32 ] , inflammation [ 33 , 34 ] , apoptosis [ 35 ] , autophagy [ 36 ] and so on.”
Kushnir, О. Y., Kushnir, О. Y., Yaremii, І. М., & Yaremii, K. M. (2024) · Biolohichni systemy · doi:10.31861/biosystems2024.02.215
Zhang, X., Zhu, L.-H., Ma, J., Zheng, Y., Yang, X.-J., Yang, L., Dong, Y., Zhang, Y., Liu, B., & Li, L.-R. (2024) · Journal of Traditional Chinese Medical Sciences · doi:10.1016/j.jtcms.2024.08.004
Miyaji, T., Kasuya, R., Sawada, A., Sawamura, D., Kitaoka, Y., & Miyazaki, M. (2024) · Physiological Reports · doi:10.14814/phy2.70048
Yazdanimoghaddam, F., Rezazadeh, H., Soltani, N., Mehranfard, N., Dastgerdi, A. H., Rad, M. G., & Ghasemi, M. (2024) · Doklady Biochemistry and Biophysics · doi:10.1134/s1607672924600386 · Cited by 1
Leow, S.-S., Khoo, J., Lee, W.-K., Hoh, C.-C., Fairus, S., Sambanthamurthi, R., & Hayes, K. C. (2024) · Journal of Applied Genetics · doi:10.1007/s13353-024-00880-1
“It also inhibited cell migration and invasion by suppressing epithelial-mesenchymal transition (Liu et al. 2018).”
Jubair, S., Hadi, S. M., Farhan, N. H., & Dhefer, I. H. (2024) · Human Gene · doi:10.1016/j.humgen.2024.201271
Xing, X., Zeng, Z., Wang, Y., Pan, B., & Huang, X. (2024) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.2411
“…have been reported to be associated with almost all diseases, such as cancer (Noorolyai et al., 2019; Xue et al., 2021), cardiovascular diseases (Qin et al., 2021; Zhang et al., 2018), nervous system diseases (Gabbouj et al., 2019; Sharma & Mehan, 2021), and metabolic diseases (Huang et al., 2018).”
BackgroundSelf-citationMo, F., An, T., Yang, N., Zhao, D.-D., Zhang, D.-W., Jiang, G., & Gao, S.-H. (2024) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2024.100408
Duarte, P. M., Gurgel, B. C. D. V., Miranda, T. S., Sardenberg, J., Gu, T., & Aukhil, I. (2024) · PLoS ONE · doi:10.1371/journal.pone.0296925
“…various stimuli (e.g., cytokines, growth factors, cellular stresses, and insulin) and regulates several biological processes (e.g., cellular survival, apoptosis, autophagy, proliferation, growth, motility, transcription, and translation) involved in periodontitis and other diseases [29, 30].”
BackgroundTokuda, H., Hori, T., Mizutani, D., Hioki, T., Kojima, K., Onuma, T., Enomoto, Y., Doi, T., Matsushima-Nishiwaki, R., Ogura, S., et al. (2024) · World Journal of Clinical Cases · doi:10.12998/wjcc.v12.i2.302
“Akt is known to play an important role in human platelet activation[6,9-14], and impairment of Akt signalling is closely related to insulin resistance, a central pathology of T2DM[16,17].”
Liu, R., Ma, T., He, Z., Chen, G., Gu, H., & Wan, Z. (2024) · Journal of Food Biochemistry · doi:10.1155/2024/5226432
PATHOGENIC MECHANISMS OF HEART FAILURE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Ivanchenko, V., Gagarina, A., Goryanskaya, I. Y., Soldatova, O. V., & Ushakov, A. (2023) · Complex Issues of Cardiovascular Diseases · doi:10.17802/2306-1278-2023-12-4s-162-172
Chavan, R., Khatib, N., & Patil, V. S. (2023) · Journal of Young Pharmacists · doi:10.5530/jyp.2023.15.91
“44 In both normal and abnormal cardiac hypertrophy, several studies have shown that the PI3K-AKT pathway regulates cardiomyocyte size, survival, angiogenesis, and inflammation.”
Metadata
- Authors
- Huang, X., Liu, G., Guo, J., & Su, Z.
- Affiliations
- Guangdong Pharmaceutical University (CN)
- Shenzhen Center for Disease Control and Prevention (CN)
- Corresponding author
- Guo, Jiao
- Su, Zhengquan
- Venue
- International Journal of Biological Sciences
- Publisher
- Ivyspring International Publisher
- Published
- 2018
- Volume
- 14
- Issue
- 11
- Pages
- 1483-1496
- ISSN
- 1449-2288 (ISSN-L)
- PMC
- PMC6158718
- OpenAlex
- W2886504687
- Cited by
- 1,673
- References
- 171
- Citations by year
- 2026: 197 · 2025: 296 · 2024: 282 · 2023: 258 · 2022: 246 · 2021: 211 · 2020: 136 · 2019: 44 · 2018: 3
- FWCI
- 9.71
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- International Journal of Biological Sciences (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (2017-02, 81173107)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- PI3K/Akt signaling, obesity, type 2 diabetes, insulin resistance, hyperglycemia, skeletal muscle, adipose tissue, liver, pancreas, therapeutic target, metabolic disorders
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Humans, Insulin Resistance, Obesity, Signal Transduction, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review